NDC 61570-110

ALTACE

Ramipril

ALTACE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Ramipril.

Product ID61570-110_7c58ba31-97ac-4b94-93c7-d6c9868df832
NDC61570-110
Product TypeHuman Prescription Drug
Proprietary NameALTACE
Generic NameRamipril
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1991-01-28
Marketing CategoryNDA / NDA
Application NumberNDA019901
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameRAMIPRIL
Active Ingredient Strength1 mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 61570-110-01

100 CAPSULE in 1 BOTTLE (61570-110-01)
Marketing Start Date1991-01-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61570-110-01 [61570011001]

ALTACE CAPSULE
Marketing CategoryNDA
Application NumberNDA019901
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1991-01-28

Drug Details

Active Ingredients

IngredientStrength
RAMIPRIL1.25 mg/1

OpenFDA Data

SPL SET ID:0fc34cd8-86e6-4034-73bd-4263a68ba046
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 845489
  • 198189
  • 261962
  • 198188
  • 104384
  • 104385
  • 845488
  • 260333
  • PHarm Class EPC
  • Angiotensin Converting Enzyme Inhibitor [EPC]
  • NUI Code
  • N0000175562
  • N0000000181
  • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    NDC Crossover Matching brand name "ALTACE" or generic name "Ramipril"

    NDCBrand NameGeneric Name
    61570-120ALTACEALTACE
    61570-110ALTACEALTACE
    61570-112ALTACEALTACE
    61570-111ALTACEALTACE
    0054-0106RamiprilRamipril
    0054-0107RamiprilRamipril
    0054-0108RamiprilRamipril
    0054-0109RamiprilRamipril
    10544-588RamiprilRamipril
    16729-152RamiprilRamipril
    16729-153RamiprilRamipril
    16729-154RamiprilRamipril
    16729-155RamiprilRamipril
    17856-0108RAMIPRILRAMIPRIL
    21695-821Ramiprilramipril
    21695-822Ramiprilramipril
    21695-823Ramiprilramipril
    31722-271RamiprilRamipril
    31722-272RamiprilRamipril
    31722-273RamiprilRamipril
    31722-274RamiprilRamipril
    33261-903RamiprilRamipril
    33261-967RamiprilRamipril
    42291-692RamiprilRamipril
    43063-303RamiprilRamipril
    43063-502RamiprilRamipril
    45865-441RamiprilRamipril
    45865-443RamiprilRamipril
    50090-1118RamiprilRamipril
    50090-1120RamiprilRamipril
    50090-1354RamiprilRamipril
    50090-2169RamiprilRamipril
    50090-2577RamiprilRamipril
    50090-3059RamiprilRamipril
    50090-3873RamiprilRamipril

    Trademark Results [ALTACE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ALTACE
    ALTACE
    76171261 2552254 Dead/Cancelled
    King Pharmaceuticals, Inc.
    2000-11-27
    ALTACE
    ALTACE
    74092062 1812659 Live/Registered
    KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC
    1990-08-28

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.